Skip to main content

CORRECTION article

Front. Immunol.
Sec. Cancer Immunity and Immunotherapy
Volume 15 - 2024 | doi: 10.3389/fimmu.2024.1353835

Arachidonate 15-lipoxygenase mediated production of Resolvin D5n-3 DPA abrogates pancreatic stellate cell induced cancer cell invasion

Gabriel Aguirre1 Michelle R. Goulart1 Tissue Bank1 Jesmond Dalli1 HEMANT M. KOCHER1*
  • 1Queen Mary University of London, United Kingdom

This article is a correction to:

Arachidonate 15-lipoxygenase-mediated production of Resolvin D5n-3 DPA abrogates pancreatic stellate cell-induced cancer cell invasion
Read original article

The final, formatted version of the article will be published soon.

Receive an email when it is updated
You just subscribed to receive the final version of the article

Identification was conducted using published criteria, matching retention time to synthetic or authentic standards, MRM peaks with more than five data points, a signal-to-noise ratio > 3 (UK/MAP). In a subset of samples the identity of these mediators was further confirmed by matching a minimum of six diagnostic ions in total ion count EPI spectrum to that of a reference standard (Supplementary Figure 2). [41]

Keywords: Pancreatic stellate cells (PSC), Resolvin D5, Arachidonate 15-Lipoxygenase, Tretinoin, Pancreatic carcinoma

Received: 11 Dec 2023; Accepted: 16 Jan 2024.

Copyright: © 2024 Aguirre, Goulart, Bank, Dalli and KOCHER. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Mx. HEMANT M. KOCHER, Queen Mary University of London, London, E1 4NS, United Kingdom